Christopher Rozell serves on the scientific advisory board and owns shares in Motif Neurotech, Inc. and is a listed inventor on intellectual property related to this work. He receives funding from NIH ...

Please provide your email address to receive an email when new articles are posted on . Changes in local field potential correlated with reported recovery from MDD ...

Using a novel deep brain stimulation (DBS) device capable of recording brain signals, researchers have identified a pattern of brain activity or “biomarker” related to clinical signs of recovery from ...

A team of leading clinicians, engineers, and neuroscientists has made a groundbreaking discovery in the field of treatment-resistant depression. By analyzing the brain activity of patients undergoing ...

New research in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging shows that the brain of individuals who have recovered from depression retains a heightened sensitivity to negative cues, ...

Researchers have found that even after recovery, individuals who previously experienced depression may retain a heightened sensitivity to negative cues and face challenges in regulating responses to ...